302 followers
RT @FrontPharmacol: New Research: Efficacy and safety of apatinib versus sorafenib/placebo in first-line treatment for intermediate and adv…
RT @FrontPharmacol: New Research: Efficacy and safety of apatinib versus sorafenib/placebo in first-line treatment for intermediate and adv…
New Research: Efficacy and safety of apatinib versus sorafenib/placebo in first-line treatment for intermediate and advanced primary liver cancer: A systematic review and meta-analysis https://t.co/QVmmE3EHS9 #pharmacology